| 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice … PA Heidenreich, B Bozkurt, D Aguilar, LA Allen, JJ Byun, MM Colvin, ... Journal of the American College of Cardiology 79 (17), e263-e421, 2022 | 4832* | 2022 |
| The genetic architecture of type 2 diabetes C Fuchsberger, J Flannick, TM Teslovich, A Mahajan, V Agarwala, ... Nature 536 (7614), 41-47, 2016 | 1247 | 2016 |
| Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction S Ather, W Chan, B Bozkurt, D Aguilar, K Ramasubbu, AA Zachariah, ... Journal of the American College of Cardiology 59 (11), 998-1005, 2012 | 814 | 2012 |
| Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the … EC Perin, JT Willerson, CJ Pepine, TD Henry, SG Ellis, DXM Zhao, ... Jama 307 (16), 1717-1726, 2012 | 542 | 2012 |
| Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not … SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ... Circulation 140 (7), e294-e324, 2019 | 481 | 2019 |
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME … JH Traverse, TD Henry, SG Ellis, CJ Pepine, JT Willerson, DXM Zhao, ... Jama 306 (19), 2110-2119, 2011 | 467 | 2011 |
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial JH Traverse, TD Henry, CJ Pepine, JT Willerson, DXM Zhao, SG Ellis, ... Jama 308 (22), 2380-2389, 2012 | 464 | 2012 |
| Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific … B Bozkurt, D Aguilar, A Deswal, SB Dunbar, GS Francis, T Horwich, ... Circulation 134 (23), e535-e578, 2016 | 438 | 2016 |
| Diabetes, left ventricular systolic dysfunction, and chronic heart failure MR MacDonald, MC Petrie, NM Hawkins, JR Petrie, M Fisher, R McKelvie, ... European heart journal 29 (10), 1224-1240, 2008 | 341 | 2008 |
| Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial D Aguilar, SD Solomon, L Køber, JL Rouleau, H Skali, JJV McMurray, ... Circulation 110 (12), 1572-1578, 2004 | 329 | 2004 |
| Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association JJ Joseph, P Deedwania, T Acharya, D Aguilar, DL Bhatt, DA Chyun, ... Circulation 145 (9), e722-e759, 2022 | 277 | 2022 |
| Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes D Aguilar, B Bozkurt, K Ramasubbu, A Deswal Journal of the American College of Cardiology 54 (5), 422-428, 2009 | 261 | 2009 |
| Metformin use and mortality in ambulatory patients with diabetes and heart failure D Aguilar, W Chan, B Bozkurt, K Ramasubbu, A Deswal Circulation: Heart Failure 4 (1), 53-58, 2011 | 253 | 2011 |
| A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance K Ramasubbu, A Deswal, C Herdejurgen, D Aguilar, AE Frost International journal of general medicine, 279-286, 2010 | 153 | 2010 |
| Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study A Gonçalves, B Claggett, PS Jhund, W Rosamond, A Deswal, D Aguilar, ... European heart journal 36 (15), 939-945, 2015 | 137 | 2015 |
| Case report: evidence of autochthonous Chagas disease in southeastern Texas MN Garcia, D Aguilar, R Gorchakov, SN Rossmann, SP Montgomery, ... The American journal of tropical medicine and hygiene 92 (2), 325, 2015 | 133 | 2015 |
| Clinical uses of low-molecular-weight heparins D Aguilar, SZ Goldhaber Chest 115 (5), 1418-1423, 1999 | 131 | 1999 |
| Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus D Aguilar, A Deswal, K Ramasubbu, DL Mann, B Bozkurt The American journal of cardiology 105 (3), 373-377, 2010 | 128 | 2010 |
| The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury Y Ye, JR Perez-Polo, D Aguilar, Y Birnbaum Basic research in cardiology 106, 925-952, 2011 | 123 | 2011 |
| Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo R Bentley-Lewis, D Aguilar, MC Riddle, B Claggett, R Diaz, K Dickstein, ... American heart journal 169 (5), 631-638. e7, 2015 | 121 | 2015 |
